CD
TEVA icon

Carl Domino’s Teva Pharmaceuticals TEVA Stock Holding History

Carl Domino’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-536
Closed -$33K – 172
2015
Q1 		$33K Sell
536
-12,632
-96% -$734K 0.02% 164
2014
Q4 		$757K Sell
13,168
-375
-3% -$20.9K 0.41% 72
2014
Q3 		$728K Sell
13,543
-7,312
-35% -$387K 0.39% 68
2014
Q2 		$1.09M Buy
20,855
+6,915
+50% +$353K 0.54% 61
2014
Q1 		$737K Buy
13,940
+55
+0.4% +$2.54K 0.39% 70
2013
Q4 		$557K Sell
13,885
-1,312
-9% -$51.7K 0.3% 77
2013
Q3 		$574K Sell
15,197
-48,084
-76% -$1.88M 0.33% 73
2013
Q2 		$2.48M Buy
+63,281
New +$2.46M 1.4% 24

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Carl Domino's TEVA Position: Q2 2015 in Review

Carl Domino sold out of Teva Pharmaceuticals (TEVA) in Q2 2015, closing a stake of 536 shares — an estimated $33K sold.

Carl Domino first reported a position in TEVA in Q2 2013 and held it in 8 quarters. The position peaked at $2.48M in Q2 2013. 818 funds tracked by Wall St. Rank hold TEVA as of Q2 2015.

  • Carl Domino reported no remaining Teva Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Carl Domino sold 536 Teva Pharmaceuticals shares in Q2 2015, an estimated $33K.
  • Carl Domino first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 8 quarters.
  • Carl Domino's Teva Pharmaceuticals position peaked at $2.48M in Q2 2013.
  • 818 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2015.

Based on Carl Domino's 13F filing for Q2 2015, filed 20 Jul 2015.